Vestibular Schwannoma Clinical Trials
Here are the 6 most popular medical studies for vestibular schwannoma
Surface Acoustic Wave Patch Device
PainShield SAW Patch Device for Trigeminal Neuralgia
This is a double blinded randomized control trial of a Surface Acoustic Wave Patch device for the treatment of Trigeminal Neuralgia. This will be a crossover study for the group that receives the sham device. Subjects will be monitored for subjective criteria of pain and quality of life, as well as objective measurement of analgesic usage.
Corticosteroid
Depo-medrol +1 More for Restless Legs Syndrome
The purpose of this study is to determine whether, in a randomized, placebo-controlled trial, restless legs syndrome (RLS) can be caused by pinched and damaged foot nerves called neuromas.
Popular filter options for vestibular schwannoma trials
Acoustic Neuroma Clinical Trials
View 6 Acoustic Neuroma medical studies.
Proton Beam Therapy
Proton Radiation Therapy for Acoustic Neuroma
This trial is testing a new type of radiation called proton radiation to see if it can better target small tumors while sparing normal surrounding tissues. They will deliver the proton radiation using fractionated stereotactic radiotherapy (FSRT) and will monitor long-term hearing preservation and tumor growth.
Tyrosine Kinase Inhibitor
Crizotinib for Acoustic Neuroma
This trial will test a new drug, crizotinib, on people with Neurofibromatosis Type 2 who have a progressive vestibular schwannoma. The drug will be taken orally, continuously, for 28 days at a time, for up to 12 cycles.
Vestibular Schwannoma Clinical Trials With No Placebo
View 48 vestibular schwannoma medical studies that do not have a placebo group.
HS-1000 recording for Intracranial Vasospasm
HeadSense (HS)-1000 device, a proprietary non-invasive brain monitor, is expected to safely and accurately monitor physiological signs of the brain with minimal discomfort to patients, providing information about normal or abnormal brain-related conditions and providing decision-making support for physicians. The investigators hypothesize that the HS-1000 is capable of detecting vasospasm using the raw acoustic data derived from the noninvasive procedure.
Proton Beam Therapy
Proton Radiation Therapy for Acoustic Neuroma
This trial is testing a new type of radiation called proton radiation to see if it can better target small tumors while sparing normal surrounding tissues. They will deliver the proton radiation using fractionated stereotactic radiotherapy (FSRT) and will monitor long-term hearing preservation and tumor growth.
Surgery
Surgical Treatments for Neuroma Pain
This trial is testing a new surgical treatment for amputees with symptomatic neuromas (nerve tumors that cause pain and disability). The new treatment is compared to two other contemporary surgical approaches, with the goal of finding which is most effective.
View More Vestibular Schwannoma Trials
See another 23 medical studies focused on vestibular schwannoma.
Frequently Asked Questions
Introduction to vestibular schwannoma
What are the top hospitals conducting vestibular schwannoma research?
Cutting-edge hospitals across the United States are making significant strides in clinical trials for vestibular schwannoma, a rare condition affecting the nerves responsible for balance and hearing. In Boston, Massachusetts General Hospital is leading the charge with three ongoing trials focused on this unique tumor. Since their first recorded trial in 2009, they have been at the forefront of research and innovation to better understand and treat vestibular schwannoma. Nearby, at Massachusetts Eye and Ear Infirmary, two active clinical trials are underway as part of their commitment to advancing knowledge surrounding this condition. Remarkably, they started their journey in exploring treatments for vestibular schwannoma only three years ago in 2018.
Beyond Boston's borders lies another hub of groundbreaking research - Salt Lake City's University of Utah. With two ongoing clinical trials dedicated to vestibular schwannoma and a history that dates back to their inaugural trial in 2013, they continue to contribute valuable insights into this complex disease. Meanwhile, Vanderbilt University Medical Center in Nashville joined the ranks more recently with two current studies focusing on vestibular schwannoma since recording its first trial just last year in 2021.
While Specialty Physician Associates located in Bethlehem may not have any completed trials under their belt yet regarding vestibular schwannoma treatment options; nevertheless holds promise through its engagement with two active investigations aimed at expanding our understanding of this condition further.
These esteemed medical institutions serve as beacons of hope for individuals affected by vestibular schwannomas worldwide by offering them access to cutting-edge therapies while helping advance scientific knowledge about these rare tumors that impact quality of life significantly
Which are the best cities for vestibular schwannoma clinical trials?
Baltimore, Maryland; Boston, Massachusetts; and Chicago, Illinois are the top cities for vestibular schwannoma clinical trials. Baltimore leads with 8 active trials focusing on treatments like Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer and Regenerative peripheral nerve interface (RPNI). Boston follows closely behind with 7 ongoing studies investigating interventions such as Aspirin and Chronic Motion-modulated Stimulation. Meanwhile, Chicago has 6 active trials exploring treatments like Active device plus standard of care. These cities offer individuals diagnosed with vestibular schwannoma access to cutting-edge research that may lead to improved treatment options and outcomes.
Which are the top treatments for vestibular schwannoma being explored in clinical trials?
Vestibular schwannoma, a benign tumor affecting the nerves responsible for balance and hearing, is an area of active research. Clinical trials are exploring various treatments to combat this condition. Among them are bevacizumab, which has shown promise in reducing tumor size; stereotactic radiosurgery (SRS), a non-invasive procedure delivering focused radiation; and everolimus, an oral medication that targets tumor growth pathways. These treatments offer hope for patients with vestibular schwannoma by providing alternative therapeutic options beyond surgical intervention.
What are the most recent clinical trials for vestibular schwannoma?
Exciting advancements are being made in the realm of vestibular schwannoma treatment, with recent clinical trials offering promising prospects. One such trial focuses on the utilization of a SAM ultrasound device and diclofenac patch to address this condition. The study is currently in Phase 2, having become available on 6/3/2023. Another investigation explores the same intervention but is in its earlier stages, as it has reached Phase 1 since becoming available on 6/1/2023. Additionally, research involving rapid acoustic pulse (RAP) therapy has progressed to Phase 4 after becoming accessible on both 2/7/2023 and 12/14/2022 respectively. These studies mark significant strides towards enhancing therapeutic approaches for individuals affected by vestibular schwannoma.
What vestibular schwannoma clinical trials were recently completed?
In recent times, several clinical trials investigating vestibular schwannoma have reached completion, presenting significant strides in the field. Notably, a trial sponsored by the National Institute on Deafness and Other Communication Disorders (NIDCD) concluded successfully. The study focused on evaluating novel treatment approaches for this type of tumor. These remarkable advancements highlight the commitment of researchers to advancing our understanding and management of vestibular schwannoma, offering hope for patients grappling with this condition.